Current Signal Transduction Therapy

Aims & Scope

In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders.

The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.

The journal publishes timely in-depth/mini reviews, research article and drug clinical trial studies in the field of signal transduction therapy.

Thematic issues are also published to cover selected areas of signal transduction therapy.

Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases.

Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.

View Aims & Scope

---

Metrics & Ranking

Journal Rank

Year	Value
2024	24547

Journal Citation Indicator

Year	Value
2024	50

SJR (SCImago Journal Rank)

Year	Value
2024	0.150

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	22

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases

  Citation: 78

  Authors: Charles, Eric

• Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)

  Citation: 66

  Authors: Zofia, Anna, Wojciech, Anna, Cezary

• Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops

  Citation: 57

  Authors: Viktoria, Chul, Diane, Natalia, Vida, Bernd

• Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy

  Citation: 56

  Authors: Bharat, Gautam, Asha, Haruyo

• Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes

  Citation: 50

  Authors: Tracey, David

• Leptin Signaling: A Key Pathway in Immune Responses

  Citation: 49

  Authors: Claudio, Elaine, Giuseppe, Antonio

• Protein O-GlcNAcylation: A Critical Regulator of the Cellular Response to Stress

  Citation: 47

  Authors: John, Richard

• Multimodal Medical Image Fusion Techniques – A Review

  Citation: 38

  Authors: T., B. Chandra, S. Srinivas

• Signal Transduction Therapy with Rationally Designed Kinase Inhibitors

  Citation: 38

  Authors: Gyorgy, Laszlo, Daniel, Balint, Csaba, Zoltan, Frigyes, Jeno, Istvan, Janos, Zoltan, Doris, Henrik, Gerhard, Bert, Axel

• Fluoride Interactions: From Molecules to Disease

  Citation: 37

  Authors: Anna, Jiri, Russell, Niloufer

---